NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/21/2026
Back to search
Official data from USPTO
PHASIUM BY MEGMEET
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/22/2026
Trademark type
Combined
Nice classes
10
Filing date
10/11/2018
Registration date
10/15/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2026
Last transaction
03/22/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
03/16/2015
First use in commerce
03/16/2015
Drawing code
3
Owner type
03
Owner location
SAN JOSE, CA, US
Examiner
SCHLEGELMILCH, JONATHON A
Current location
Historical data usage
Mark description
The mark consists of "PHASIUM BY MEGMEET" is all in upper case letters. "PHASIUM" is underlined twice, with the bottom line ends aligned starting from the middle of "A" and ending after the "I". "BY" is placed under the right end of the bottom line, followed by "MEGMEET" under the right end of the first line.
Holders and representatives
Holders
Megmeet USA, Inc
Megmeet USA, Inc
Representatives
Andrew T. Rissler Patel & Almeida PC
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometershematology analyzerssample preparation devicerelated data management software sold as a unit; Medical apparatus and instrument for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; Medical apparatus and instruments for diagnostic radiopharmaceutical use; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring oxymetorygas analysis and vital signs; Medical apparatus and instruments for monitoring oxymetorygas analysisvital signsblood properties and respiratory events; Medical apparatus and instruments for monitoring oxymetorygas analysisvital signsblood properties and respiratory events and software sold therewith as a unit; Medical apparatus and instruments for monitoring vital signsblood properties and respiratory events; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus and instruments for treating osteoarthritis and osteoporosis; Medical apparatus and instruments for treating osteoarthritisosteoporosisosteotraumatic injuriesdegenerative bone diseases and joint diseases; Medical apparatus and instruments for treating osteotraumatic injuriesdegenerative bone diseases and joint diseases; Medical apparatus and instruments for use in orthopedic surgery; Medical apparatus and instruments for use in positron emission tomography (PET) imaging; Medical apparatus and instruments for use in positron emission tomography (PET) imaging used to monitor brainheart and metabolic functions; Medical apparatus and instruments for use in surgery; Medical apparatus and instruments relating to neurovegetative reactivity; Medical apparatus and instrumentsa handheld ultrasound unit for cardiac diagnosisscreening and cardiovascular patient follow-up; Medical apparatusinvasive and non-invasive ventilation apparatus and instruments; Medical instruments and apparatusdelivery apparatus for fibrin sealant; Medical instrumentsorthopedic apparatus and instruments; Medical and surgical apparatus and instrumentsdevices used in orthopedic surgery to position surgical instrumentsimplants and/or patients' limbs; Medical and surgical apparatus and instrumentsorthopedic fixation device used in orthopedic transplant and/or implant surgery; Medical and surgical apparatus and instrumentsvertebral osteosynthesis staple-shaped apparatus and instruments; Electro-surgical motors being part of surgical and medical apparatus and instruments for use in general surgery; Light emitting diode (LED) apparatus for lightingincorporated into medical instruments; Surgical apparatus and instruments for medicaldental or veterinary use; Surgical and medical apparatus and instruments for use in general surgery ; Surgical and medical apparatus and instruments for use in orthopedic surgery
Publications
History of USPTO decisions and trademark events.
33 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/21/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/09/2026
ES8R
TEAS SECTION 8 RECEIVED
09/26/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/15/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/17/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/17/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/17/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/17/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/17/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/15/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/30/2019
PUBO
PUBLISHED FOR OPPOSITION
07/30/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/10/2019
ALIE
ASSIGNED TO LIE
06/21/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/10/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/05/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/17/2019
GNFR
FINAL REFUSAL E-MAILED
05/17/2019
CNFR
FINAL REFUSAL WRITTEN
05/17/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/27/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/26/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/26/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/29/2019
GNRT
NON-FINAL ACTION E-MAILED
01/29/2019
CNRT
NON-FINAL ACTION WRITTEN
01/29/2019
DOCK
ASSIGNED TO EXAMINER
01/22/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/23/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/22/2018
NWAP
NEW APPLICATION ENTERED
10/15/2018
Continuous trademark protection
Get notified about every new filing that threatens PHASIUM BY MEGMEET or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.